Correction: Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome — a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)

• Corinna Engel,
• Mario Rüdiger,
• Manon J. N. L. Benders,
• Frank van Bel,
• Karel Allegaert,
• Gunnar Naulaers,
• Dirk Bassler,
• Katrin Klebermaß-Schrehof,
• Maximo Vento,
• Ana Vilan,
• Mari Falck,
• Isabella Mauro,
• Marjo Metsäranta,
• Sampsa Vanhatalo,
• Jan Mazela,
• Tuuli Metsvaht,
• Roselinda van der Vlught,
• Axel R. Franz,
• for the ALBINO Study Group

Affiliations

Corinna Engel

Center for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen

Mario Rüdiger

Universitätsklinikum C. G. Carus - Medizinische Fakultät der TU Dresden

Manon J. N. L. Benders

Universitair Medisch Centrum Utrecht

Frank van Bel

Universitair Medisch Centrum Utrecht

Karel Allegaert

University Hospitals Leuven

Gunnar Naulaers

University Hospitals Leuven

Dirk Bassler

UniversitaetsSpital Zuerich

Katrin Klebermaß-Schrehof

Medizinische Universitaet Wien

Maximo Vento

Hospital Universitario y Politécnico La Fe

Ana Vilan

Centro Hospitalar Universitário São João Porto

Mari Falck

Oslo Uni- versitetssykehus HF

Isabella Mauro

Azienda sanitaria universitaria integrata di Udine

Marjo Metsäranta

Helsinki University Hospital (HUS)

Sampsa Vanhatalo

Helsinki University Hospital (HUS)

Jan Mazela

Department of Neonatology, Poznan University of Medical Sciences

Tuuli Metsvaht

Tartu University Hospital

Roselinda van der Vlught

ACE Pharmaceuticals BV

Axel R. Franz

Center for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen

for the ALBINO Study Group